Baclofen
Baclofen Accord is administered by injection or continuous infusion into the spinal canal, directly into the cerebrospinal fluid (intrathecal injection), and relieves severe muscle stiffness (spasticity). The first injection is in the form of a bolus, and then the medicine is administered by infusion. Baclofen Accord is used to treat severe, long-term muscle tension (spasticity) that occurs in various diseases, such as:
Baclofen Accord is used in adults and children over 4 years of age. It is used when other oral medications, including baclofen, have been ineffective or have caused unacceptable side effects.
Before starting treatment with Baclofen Accord, the patient should discuss the following with their doctor, pharmacist, or nurse:
The patient should immediately contact their doctor if they experience any of the following symptoms during treatment with Baclofen Accord:
If the patient thinks that Baclofen Accord is not working as well as usual, they should immediately contact their doctor. It is essential to ensure that there are no problems with the pump. The patient will be closely monitored in a fully equipped environment with personnel during the screening phase and dose adjustment immediately after pump implantation. The patient will be regularly evaluated for dosage requirements, possible side effects, or signs of infection. The functioning of the delivery system will also be checked. The patient should not miss hospital visits related to pump refilling.
Baclofen Accord should not be used in children under 4 years of age. Older children must have sufficient body weight to accommodate the implanted pump. Clinical data on the use of the medicine in children under four years of age are limited.
Some patients over 65 years of age have been treated with intrathecal baclofen without particular problems during clinical trials. However, experience with oral baclofen tablets shows that this group of patients may be more susceptible to side effects. Therefore, elderly patients should be closely monitored for side effects.
The patient should tell their doctor or nurse about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. If the patient is taking any of the following medicines, they should discuss this with their doctor, as they may affect Baclofen Accord or Baclofen Accord may interact with these medicines:
Concomitant use of general anesthetics may increase the risk of cardiac arrhythmias and seizures.
The patient should avoid consuming alcohol during treatment with Baclofen Accord, as this may lead to unwanted intensification or unpredictable change in the effect of the medicine.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking Baclofen Accord. PregnancyExperience with intrathecal baclofen during pregnancy is limited. Baclofen Accord should not be used during pregnancy unless the expected benefits to the mother outweigh the potential risk to the fetus. BreastfeedingBaclofen Accord passes into breast milk, but after intrathecal administration, a low concentration is expected. Therefore, Baclofen Accord can be used during breastfeeding.
During treatment with Baclofen Accord, the ability to drive and use machines may be significantly impaired. In some people, Baclofen Accord may cause drowsiness, dizziness, double vision, difficulty controlling movements, or hallucinations. The patient should not drive or operate machinery until these symptoms have resolved, if they occur. Before driving or operating machinery, the patient should consult their doctor.
Baclofen Accord, 50 micrograms/mL solution for injection, contains less than 1 mmol of sodium (23 mg) per 1 mL, which means that the medicine is essentially "sodium-free". Baclofen Accord, 0.5 mg/mL solution for infusion, contains 70.78 mg of sodium in 20 mL, which corresponds to 3.5% of the WHO-recommended maximum daily intake of sodium, which is 2 g for an adult. Baclofen Accord, 2 mg/mL solution for infusion, contains less than 1 mmol of sodium (23 mg) per 5 mL, which means that the medicine is essentially sodium-free. Baclofen Accord, 2 mg/mL solution for infusion, contains 70.78 mg of sodium in 20 mL, which corresponds to 3.5% of the WHO-recommended maximum daily intake of sodium, which is 2 g for an adult.
This medicine should always be taken exactly as prescribed by the doctor or pharmacist. If the patient has any doubts, they should consult their doctor or pharmacist. Only a doctor can change the dose of the medicine. Baclofen Accord can only be administered by a specially qualified doctor.
The dose depends on the patient's condition. The doctor will determine the dose after examining the patient's reaction to the medicine. First, the doctor will give the patient a single dose of Baclofen Accord to check if it is suitable for them. During this period, heart and lung function will be closely monitored. If the symptoms improve, a special pump will be implanted in the chest or abdominal wall, which will continuously administer Baclofen Accord. The doctor will provide the patient with all necessary instructions for using the pump and information about dosing. The patient should make sure they understand everything. The dose depends on the patient's reaction to the medicine. Treatment starts with a small dose, which is gradually increased over several days under the doctor's supervision until the target dose is reached. Side effects are more likely if the initial dose is too high or the dose is increased too quickly. To avoid these reactions, which can be serious, it is essential to ensure that the pump does not run out. The patient should not miss hospital visits.
If muscle spasticity does not improve or if spasms start to recur, gradually or suddenly, the patient should immediately contact their doctor.
It is crucial that the patient and their caregivers can recognize the symptoms of Baclofen Accord withdrawal. These may occur suddenly or gradually, for example, due to malfunction of the pump due to battery problems, catheter problems, or alarm malfunction. Withdrawal symptoms include:
If the patient does not receive immediate treatment, more severe side effects may occur after these symptoms.
Baclofen Accord can only be administered into the spinal canal (intrathecal administration).
To be determined by the doctor. In some patients, during long-term treatment with Baclofen Accord, the medicine may become less effective. To prevent this, the doctor may recommend occasional breaks in treatment.
It is essential that the patient and their caregivers can recognize the symptoms of Baclofen Accord overdose. This may occur if the pump does not work correctly. The patient should immediately inform their doctorif they experience any of the following symptoms:
If it is necessary to discontinue treatment, only a doctor can do this by gradually reducing the dose to avoid side effects. Abrupt discontinuation of intrathecal Baclofen Accord may cause withdrawal symptoms, which in some cases have been fatal. If the patient has any further doubts about the use of this medicine, they should consult their doctor or nurse.
Like all medicines, Baclofen Accord can cause side effects, although not everybody gets them. It is also known that many of these side effects are related to the underlying disease for which the patient is being treated. Side effects may occur with the following frequency: Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
The following side effects occur more frequently in patients with spasticity of cerebral origin: seizures, headaches, nausea, vomiting, and difficulty urinating Uncommon(may affect up to 1 in 100 people)excessive feeling of coldness involuntary eye movements (nystagmus) difficulty controlling movements (ataxia) memory impairment mood disorders, euphoria, paranoia, hallucinations, suicidal thoughts and attempts intestinal obstruction, difficulty swallowing, loss of taste, dehydration high blood pressure, slow heart rate deep vein thrombosis red or pale skin, excessive sweating hair loss Rare(may affect up to 1 in 1,000 people)life-threatening withdrawal symptoms due to problems with drug administration Frequency not known(frequency cannot be estimated from the available data)worsening of spinal curvature (scoliosis) inability to achieve or maintain an erection (erectile dysfunction) Description of withdrawal symptoms, see "Discontinuation of Baclofen Accord". Description of overdose symptoms, see "Overdose of Baclofen Accord". There have been reports of problems with the pump and delivery system, such as infections, meningitis, or inflammation at the tip of the catheter.
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should inform their doctor, pharmacist, or nurse. Side effects can also be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocides of the Office for Registration of Medicinal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, more information can be collected on the safety of the medicine.
The medicine should be stored out of sight and reach of children. There are no special precautions for storing the medicine. Do not use this medicine after the expiry date stated on the carton and ampoule/vial after EXP. The expiry date refers to the last day of the month stated. After opening/dilution: use immediately. Since the use of the medicine is limited to hospital use, the disposal of unused medicine is the responsibility of the hospital.
Baclofen Accord, 50 micrograms/mL solution for injection: 1 ampoule with 1 mL of solution for injection contains 0.05 mg of baclofen. Baclofen Accord, 0.5 mg/mL solution for infusion: 1 mL of solution for infusion contains 0.5 mg of baclofen. 1 vial with 20 mL of solution for infusion contains 10 mg of baclofen. Baclofen Accord, 2 mg/mL solution for infusion: 1 mL of solution for infusion contains 2.0 mg of baclofen. 1 ampoule with 5 mL of solution for infusion contains 10 mg of baclofen. 1 vial with 20 mL of solution for infusion contains 40 mg of baclofen. The other ingredients are sodium chloride, water for injections.
Baclofen Accord is available in four different sizes containing baclofen in amounts of 50 micrograms in 1 mL, 10 mg in 20 mL, 10 mg in 5 mL, and 40 mg in 20 mL. Baclofen Accord, 50 micrograms/mL solution for injection: Baclofen Accord is a clear, colorless solution in a 1 mL ampoule made of transparent type I glass. Each pack contains 1 or 5 ampoules. Baclofen Accord, 0.5 mg/mL solution for infusion: Baclofen Accord is a clear, colorless solution in a 20 mL vial made of clear type I glass with a gray aluminum flip-off seal. Each pack contains 1 vial. Baclofen Accord, 2 mg/mL solution for infusion: Baclofen Accord is a clear, colorless solution in a 5 mL ampoule made of transparent type I glass. Each pack contains 1, 5, or 10 ampoules. Baclofen Accord is a clear, colorless solution in a 20 mL vial made of clear type I glass with a green aluminum flip-off cap. Each pack contains 1 vial. Not all pack sizes may be marketed.
Accord Healthcare Polska Sp.z o.o., ul. Taśmowa 7, 02-677 Warsaw, Tel: +48 22 577 28 00
Accord Healthcare Polska Sp.z o.o., ul. Lutomierska 50, 95-200 Pabianice
Member State | Medicinal product name |
Denmark | Baclofen Accord |
Norway | Baclofen Accord |
Poland | Baclofen Accord |
Sweden | Baclofen Accord |
The following information is intended for healthcare professionals only.
Baclofen Accord is intended for intrathecal administration or continuous infusion. The medicine should not be mixed with other infusion or injection solutions. Ampoules are for single use only. Unused solution should be discarded. After opening and/or dilution: use immediately. The solution should only be used if it is clear and colorless and free of particles. Information on dosing, administration, and other information can be found in the Summary of Product Characteristics and the patient information leaflet. The medicine should not be administered by any route other than intrathecally. Baclofen Accord should not be administered intravenously, intramuscularly, subcutaneously, or epidurally. Only pumps made of material compatible with the product and equipped with a built-in antibacterial filter should be used. Stages of testing, implantation, and dose adjustment during intrathecal administrationshould be performed in a hospital setting, in centers with special experience, under close medical supervision by qualified doctors.Due to the possibility of life-threatening or serious side effects, immediate intensive medical care should be ensured.
In the case of patients requiring concentrations other than 50 micrograms/mL, 0.5 mg/mL, and 2 mg/mL, Baclofen Accord should be diluted with sterile isotonic sodium chloride solution for injection without preservatives. Dilution should be performed under aseptic conditions.
Place your thumb on the blue dot and break (the break point is located below the blue dot)
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.